Abstract
Spontaneous intracerebral hemorrhage (SICH) remains a significant etiology of morbidity and mortality in the general population and particularly the elderly patients. Classically, SICH may be secondary to uncontrolled arterial hypertension, amyloid angiopathy, and iatrogenic coagulopathy. Rarely it reveals a malignant intracerebral tumor, a venous thrombosis, or results from the transformation of an ischemic stroke and vascular malformation rupture as well. The management of SICH remains challenging as it associates the specific treatment of the hemorrhage (medical and/or surgical) but also the associated morbidity inherent to elderly patients such as nosocomial infections particularly urinary and aspiration pneumonia, venous thrombosis, and denutrition.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Brown WR, Thore CR (2011) Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol 37:56–74
Ariesen MJ, Claus SP, Rinkel GJE, Algra A (2003) Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke 34:2060–2065
Pisani MA (2009) Considerations in caring for the critically ill older patient. J Intensive Care Med 24:83–95
Aguilar MI, Brott TG (2011) Update in intracerebral hemorrhage. Neurohospitalist 1:148–159
Kreitzer N, Adeoye O (2013) An update on surgical and medical management strategies for intracerebral hemorrhage. Semin Neurol 33:462–467
Manno EM (2012) Update on intracerebral hemorrhage. Continuum (Minneap Minn) 18:598–610
Thrift AG, McNeil JJ, Forbes A, Donnan GA (1998) Three important subgroups of hypertensive persons at greater risk of intracerebral hemorrhage. Melbourne Risk Factor Study Group. Hypertension 31:1223–1229
Sadoshima S, Yoshida F, Ibayashi S, Shiokawa O, Fujishima M (1985) Upper limit of cerebral autoregulation during development of hypertension in spontaneously hypertensive rats – effect of sympathetic denervation. Stroke 16:477–481
Salerno JA et al (1995) Brain metabolic function in older men with chronic essential hypertension. J Gerontol A Biol Sci Med Sci 50:M147–M154
Chiquete E et al (2007) Hypertensive intracerebral hemorrhage in the very elderly. Cerebrovasc Dis 24:196–201
Ruiz-Sandoval JL et al (2006) Hypertensive intracerebral hemorrhage in young people: previously unnoticed age-related clinical differences. Stroke 37:2946–2950
Pezzini A et al (2009) Cerebral amyloid angiopathy: a common cause of cerebral hemorrhage. Curr Med Chem 16:2498–2513
Itoh Y, Yamada M, Hayakawa M, Otomo E, Miyatake T (1993) Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J Neurol Sci 116:135–141
Jellinger K (1977) Cerebrovascular amyloidosis with cerebral hemorrhage. J Neurol 214:195–206
Lee SS, Stemmermann GN (1978) Congophilic angiopathy and cerebral hemorrhage. Arch Pathol Lab Med 102:317–321
Cadavid D, Mena H, Koeller K, Frommelt RA (2000) Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. A case control study in human brain biopsies. J Neuropathol Exp Neurol 59:768–773
Keage HAD et al (2009) Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review. BMC Neurol 9:3
Love S, Miners JS (2016) Cerebrovascular disease in ageing and Alzheimer’s disease. Acta Neuropathol 131:645–658
Neuropathology Group (2001) Medical Research Council Cognitive Function and Aging Study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 357:169–175
Pfeifer LA, White LR, Ross GW, Petrovitch H, Launer LJ (2002) Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology 58:1629–1634
Xuereb JH et al (2000) Neuropathological findings in the very old. Results from the first 101 brains of a population-based longitudinal study of dementing disorders. Ann N Y Acad Sci 903:490–496
Mastaglia FL, Byrnes ML, Johnsen RD, Kakulas BA (2003) Prevalence of cerebral vascular amyloid-beta deposition and stroke in an aging Australian population: a postmortem study. J Clin Neurosci 10:186–189
Arima H et al (2010) Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial. Stroke 41:394–396
Broderick J, Brott T, Tomsick T, Leach A (1993) Lobar hemorrhage in the elderly. The undiminishing importance of hypertension. Stroke 24:49–51
Ferreiro JA, Ansbacher LE, Vinters HV (1989) Stroke related to cerebral amyloid angiopathy: the significance of systemic vascular disease. J Neurol 236:267–272
Gregoire SM et al (2011) Acute ischaemic brain lesions in intracerebral haemorrhage: multicentre cross-sectional magnetic resonance imaging study. Brain 134:2376–2386
Verghese PB, Castellano JM, Holtzman DM (2011) Apolipoprotein E in Alzheimer’s disease and other neurological disorders. Lancet Neurol 10:241–252
Greenberg SM et al (1996) Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. Stroke 27:1333–1337
Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN (1996) Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer’s disease. Am J Pathol 148:2083–2095
Biffi A et al (2010) Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol 68:934–943
Nicoll JA et al (1997) High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 41:716–721
Biffi A et al (2011) APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study. Lancet Neurol 10:702–709
Montaner J (2011) Genetics of intracerebral haemorrhage: a tsunami effect of APOE ε2 genotype on brain bleeding size? Lancet Neurol 10:673–675
Vinters HV (1987) Cerebral amyloid angiopathy. A critical review. Stroke 18:311–324
Rosand J et al (2005) Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy. Ann Neurol 58:459–462
Passero S, Burgalassi L, D’Andrea P, Battistini N (1995) Recurrence of bleeding in patients with primary intracerebral hemorrhage. Stroke 26:1189–1192
Poels MMF et al (2010) Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study. Stroke 41:S103–S106
Greenberg SM, Eng JA, Ning M, Smith EE, Rosand J (2004) Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke 35:1415–1420
Sveinbjornsdottir S et al (2008) Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location. J Neurol Neurosurg Psychiatr 79:1002–1006
Debette S, Markus HS (2010) The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 341:c3666
Smith EE et al (2004) White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage. Neurology 63:1606–1612
Chen YW et al (2006) Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy. Neurology 67:83–87
Linn J et al (2008) Subarachnoid hemosiderosis and superficial cortical hemosiderosis in cerebral amyloid angiopathy. AJNR Am J Neuroradiol 29:184–186
Kumar N et al (2006) Superficial siderosis. Neurology 66:1144–1152
Kidwell CS, Greenberg SM (2009) Red meets white: do microbleeds link hemorrhagic and ischemic cerebrovascular disease? Neurology 73:1614–1615
Nordberg A, Rinne JO, Kadir A, Långström B (2010) The use of PET in Alzheimer disease. Nat Rev Neurol 6:78–87
Knudsen KA, Rosand J, Karluk D, Greenberg SM (2001) Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology 56:537–539
de Jong D, Kremer BPH, Olde Rikkert MGM, Verbeek MM (2007) Current state and future directions of neurochemical biomarkers for Alzheimer’s disease. Clin Chem Lab Med 45:1421–1434
Verbeek MM et al (2009) Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy. Ann Neurol 66:245–249
Lee A et al (2009) Retinal vascular abnormalities in patients with cerebral amyloid angiopathy. Cerebrovasc Dis 28:618–622
Flaherty ML et al (2007) The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology 68:116–121
Flibotte JJ, Hagan N, O’Donnell J, Greenberg SM, Rosand J (2004) Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology 63:1059–1064
Rosand J, Hylek EM, O’Donnell HC, Greenberg SM (2000) Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology 55:947–951
Ruff CT et al (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383:955–962
Hankey GJ (2014) Intracranial hemorrhage and novel anticoagulants for atrial fibrillation: what have we learned? Curr Cardiol Rep 16:480
Mackman N (2009) The role of tissue factor and factor VIIa in hemostasis. Anesth Analg 108:1447–1452
Sakata T et al (1995) Suppression of plasma-activated factor VII levels by warfarin therapy. Arterioscler Thromb Vasc Biol 15:241–246
Lippi G et al (2006) Influence of warfarin therapy on activated factor VII clotting activity. Blood Coagul Fibrinolysis 17:221–224
Deveras RAE, Kessler CM (2002) Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate. Ann Intern Med 137:884–888
Mayer SA et al (2008) Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 358:2127–2137
Eyal S, Hsiao P, Unadkat JD (2009) Drug interactions at the blood–brain barrier: fact or fantasy? Pharmacol Ther 123:80–104
Stöllberger C, Finsterer J (2015) Relevance of P-glycoprotein in stroke prevention with dabigatran, rivaroxaban, and apixaban. Herz 40(Suppl 2):140–145
Wessler JD, Grip LT, Mendell J, Giugliano RP (2013) The P-glycoprotein transport system and cardiovascular drugs. J Am Coll Cardiol 61:2495–2502
Rådholm K et al (2015) Older age is a strong predictor for poor outcome in intracerebral haemorrhage: the INTERACT2 study. Age Ageing 44:422–427
Chen G et al (2014) Subarachnoid extension of intracerebral hemorrhage and 90-day outcomes in INTERACT2. Stroke 45:258–260
Stein M et al (2012) Intracerebral hemorrhage in the very old: future demographic trends of an aging population. Stroke 43:1126–1128
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Berhouma, M., Jacquesson, T., Jouanneau, E. (2017). Spontaneous Intracerebral Hemorrhage in the Elderly. In: Berhouma, M., Krolak-Salmon, P. (eds) Brain and Spine Surgery in the Elderly. Springer, Cham. https://doi.org/10.1007/978-3-319-40232-1_22
Download citation
DOI: https://doi.org/10.1007/978-3-319-40232-1_22
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-40231-4
Online ISBN: 978-3-319-40232-1
eBook Packages: MedicineMedicine (R0)